Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
124.3 USD | -9.91% | -4.87% | +0.20% |
04-26 | Wall Street: the worst week of 2024 is followed by the best | CF |
04-26 | Morgan Stanley Adjusts DexCom's Price Target to $132 From $122 | MT |
Sales 2024 * | 4.33B 5.92B | Sales 2025 * | 5.15B 7.05B | Capitalization | 49.45B 67.59B |
---|---|---|---|---|---|
Net income 2024 * | 721M 986M | Net income 2025 * | 887M 1.21B | EV / Sales 2024 * | 11.8 x |
Net Debt 2024 * | 1.51B 2.06B | Net Debt 2025 * | 971M 1.33B | EV / Sales 2025 * | 9.78 x |
P/E ratio 2024 * |
70.8
x | P/E ratio 2025 * |
57.8
x | Employees | 9,550 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.23% |
Latest transcript on DexCom, Inc.
1 day | -0.75% | ||
1 week | -4.87% | ||
Current month | -10.35% | ||
1 month | -11.14% | ||
3 months | +1.95% | ||
6 months | +53.34% | ||
Current year | +0.20% |
Managers | Title | Age | Since |
---|---|---|---|
Kevin Sayer
CEO | Chief Executive Officer | 66 | 07-10-31 |
Jereme Sylvain
DFI | Director of Finance/CFO | 44 | 18-08-31 |
Chief Tech/Sci/R&D Officer | 47 | 22-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Nick Augustinos
BRD | Director/Board Member | 65 | 09-11-19 |
Mark Foletta
BRD | Director/Board Member | 63 | 14-11-18 |
Eric Topol
BRD | Director/Board Member | 69 | 09-07-08 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.46% | 18 M€ | +3.79% | - | |
1.04% | 16 M€ | -8.49% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 124.3 | -9.91% | 8,578,184 |
24-04-25 | 138 | +0.10% | 4,203,199 |
24-04-24 | 137.9 | +2.89% | 3,238,221 |
24-04-23 | 134 | +1.89% | 2,014,910 |
24-04-22 | 131.5 | +0.62% | 2,110,326 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.20% | 49.45B | |
-2.31% | 187B | |
-3.20% | 106B | |
-5.04% | 66.9B | |
+17.29% | 48B | |
+4.06% | 40.84B | |
+2.36% | 26.25B | |
+2.07% | 26.48B | |
+12.96% | 24.62B | |
-1.93% | 24.52B |
- Stock Market
- Equities
- DXCM Stock